#CityTherapeutics has finalised its #IPO, raising $200 million for a pipeline of #RNAinterference (RNAi) therapies headed by a novel #anticoagulant drug.

#CityTherapeutics has finalised its #IPO, raising $200 million for a pipeline of #RNAinterference (RNAi) therapies headed by a novel #anticoagulant drug.
Contemporary research recommends that #healthcare providers tailor #anticoagulantmedication dosages to account for consistent daily #vitamin K intake, despite traditional counseling to limit #vitaminK rich foods due to their potential impact on #anticoagulant effectiveness. #healthyaging
"UCB..announced that the #FDA has granted BTD..to CIMZIA® (certolizumab pegol) for the prevention of placenta-mediated adverse #pregnancy outcomes in #pregnant women who hv #AntiphospholipidSyndrome ..& r positive for lupus #anticoagulant.": buff.ly/nkwOOxR
via @prnewswire.bsky.social
#pharmacology
Perosphere Technologies Presents New Clinical Findings for ClotChek™ Coagulometer #USA #Danbury #Anticoagulant #ClotChek™ #Perosphere